Guidance for pharmacy teams on the new Part VIIID arrangements for specials

From March 2022, the Drug Tariff will include a new section, Part VIIID, which sets out payment arrangements for specials and imported unlicensed medicines (mainly tablets and capsules) to be paid relative to commonly identified pack sizes.

PSNC’s Dispensing and Supply team have developed the following resources to help pharmacy teams understand the new Part VIIID arrangements:

PSNC briefing titled ‘Part VIIID – Specials with reimbursement prices relative to commonly identified pack sizes‘ provides guidance on the new Part VIIID arrangements as FAQs covering the reasons for the introduction of a new section in the Drug Tariff for specials, Part VIIID price-setting processes as well as prescription endorsing and submission requirements. The briefing also includes a table comparing the key differences between Drug Tariff-listed (Part VIIIB and Part VIIID) and non-Tariff specials.

Pharmacy endorsing guidance for specials and imported unlicensed medicines factsheet. This factsheet outlines the differences in prescription endorsement requirements for both Drug Tariff-listed and non-Tariff specials.

Other useful resources

Part VIIID section of the Drug Tariff